Yi C - Search Results

1

The emerging role of the gut microbiota and its application in inflammatory bowel disease.

Wang X, Peng J, Cai P, Xia Y, Yi C, Shang A, Akanyibah FA, Mao F. Wang X, et al. Among authors: yi c. Biomed Pharmacother. 2024 Oct;179:117302. doi: 10.1016/j.biopha.2024.117302. Epub 2024 Aug 19. Biomed Pharmacother. 2024. PMID: 39163678 Free article. Review.

2

The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease.

Xu X, Ocansey DKW, Hang S, Wang B, Amoah S, Yi C, Zhang X, Liu L, Mao F. Xu X, et al. Among authors: yi c. Gut Pathog. 2022 Jun 21;14(1):26. doi: 10.1186/s13099-022-00499-9. Gut Pathog. 2022. PMID: 35729658 Free PMC article.

3

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer.

Zhou M, Wang D, Li X, Cao Y, Yi C, Wiredu Ocansey DK, Zhou Y, Mao F. Zhou M, et al. Among authors: yi c. Front Pharmacol. 2022 Oct 6;13:1016836. doi: 10.3389/fphar.2022.1016836. eCollection 2022. Front Pharmacol. 2022. PMID: 36278234 Free PMC article. Review.

4

Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers.

Wang N, Pei B, Yuan X, Yi C, Wiredu Ocansey DK, Qian H, Mao F. Wang N, et al. Among authors: yi c. Front Bioeng Biotechnol. 2022 Oct 20;10:1019459. doi: 10.3389/fbioe.2022.1019459. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36338118 Free PMC article. Review.

5

The role of NOD2 in intestinal immune response and microbiota modulation: A therapeutic target in inflammatory bowel disease.

Liu Z, Zhang Y, Jin T, Yi C, Ocansey DKW, Mao F. Liu Z, et al. Among authors: yi c. Int Immunopharmacol. 2022 Dec;113(Pt B):109466. doi: 10.1016/j.intimp.2022.109466. Epub 2022 Nov 23. Int Immunopharmacol. 2022. PMID: 36435061 Free article. Review.

6

HucMSC-Ex alleviates DSS-induced colitis in mice by decreasing mast cell activation via the IL-33/ST2 axis.

Wei Z, Tang X, Yi C, Ocansey DKW, Mao F, Mao Z. Wei Z, et al. Among authors: yi c. Am J Transl Res. 2024 Jun 25;16(6):2727-2744. doi: 10.62347/EXZE5413. eCollection 2024. Am J Transl Res. 2024. PMID: 39006299 Free PMC article.

7

The role of suppressor of cytokine signaling 3 in inflammatory bowel disease and its associated colorectal cancer.

Zhang P, Pei B, Yi C, Akanyibah FA, Mao F. Zhang P, et al. Among authors: yi c. Biochim Biophys Acta Mol Basis Dis. 2025 Feb;1871(2):167578. doi: 10.1016/j.bbadis.2024.167578. Epub 2024 Nov 19. Biochim Biophys Acta Mol Basis Dis. 2025. PMID: 39571630 Review.

8

Human umbilical cord mesenchymal stem cells derived-exosomes alleviate LPS-induced cervical inflammation and epithelial-mesenchymal transition.

Yi C, Wang H, Din MAU, Xia Y, Akanyibah FA, Mao F. Yi C, et al. Am J Transl Res. 2024 Nov 15;16(11):6903-6913. doi: 10.62347/PKYU4876. eCollection 2024. Am J Transl Res. 2024. PMID: 39678571 Free PMC article.

9

Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions.

Azhar Ud Din M, Lin Y, Lyu C, Yi C, Fang A, Mao F. Azhar Ud Din M, et al. Among authors: yi c. Mol Med. 2025 Jan 3;31(1):2. doi: 10.1186/s10020-024-01060-x. Mol Med. 2025. PMID: 39754054 Free PMC article. Review.

10

Short-Chain Fatty Acids Weaken Ox-LDL-Induced Cell Inflammatory Injury by Inhibiting the NLRP3/Caspase-1 Pathway and Affecting Cellular Metabolism in THP-1 Cells.

Yi C, Sun W, Ding L, Yan M, Sun C, Qiu C, Wang D, Wu L. Yi C, et al. Molecules. 2022 Dec 12;27(24):8801. doi: 10.3390/molecules27248801. Molecules. 2022. PMID: 36557935 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,955 results

Search Page

Filters